MedTrace Logo

Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and Mexico

NCT02381197 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2017-03-23

No results posted yet for this study

Summary

A population-based prospective cohort design will evaluate the progression of urine congophilia in pregnancy using the Congo Red Dot test by following patients longitudinally across gestation in Bangladesh and Mexico City.

Conditions

Interventions

DEVICE

Congo Red Dot test

The Congo Red Dot test is a simple dye test that detects unfolded or misfolded proteins

Sponsors & Collaborators

  • Nationwide Children's Hospital

    collaborator OTHER

  • Gynuity Health Projects

    lead OTHER

Principal Investigators

  • Irina Buhimschi, Dr · Nationwide Children's Hospital

  • Beverly Winikoff, Dr · Gynuity Health Projects

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Bangladesh
  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02381197 on ClinicalTrials.gov